References
- World Health Organization. Global tuberculosis control. Geneva: WHO; 2011. Available at: http://www.who.int/tb/publications/global_report/en/index.html (accessed).
- Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000;356: 1099–104.
- Quantiferon-TB Gold. Cellestis; 2009. Available at: http://www.cellestis.com (accessed).
- Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004;170:59–64.
- T-SPOT.TB. Oxford Immunotec; 2009. Available at: http://www.oxfordimmunotec.com (accessed).
- Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001;163:824–8.
- Haute Autorité de Santé. Synthèse de la production d'interféron-γ pour le diagnostic des infections tuberculeuses. France: Haute Autorité de Santé; 2006. Available at: http://www.hassante.fr/portail/upload/docs/application/pdf/synthese_detection_de_linterferon-gamma.pdf (accessed 13 December 2006).
- Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177–84.
- Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004;4:761–76.
- Pai M, Menzies D. Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis?Clin Infect Dis 2007;44:74–7.
- Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 2007;131:1898–906.
- Holden M, Dubin MR, Diamond PH. Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N Engl J Med 1971;285:1506–9.
- Stead WW, To T. The significance of the tuberculin skin test in elderly persons. Ann Intern Med 1987;107:837–42.
- Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008;177:1164–70.
- Higuchi K, Harada N, Fukazawa K, Mori T. Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis. Tuberculosis (Edinb) 2008;88: 244–8.
- Pathan AA, Wilkinson KA, Klenerman P, McShane H, Davidson RN, Pasvol G, et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001;167:5217–25.
- Chee CB, KhinMar KW, Gan SH, Barkham TM, Pushparani M, Wang YT. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens. Am J Respir Crit Care Med 2007;175:282–7.
- Denkinger CM, Dheda K, Pai M. Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion?Clin Microbiol Infect 2011;17:806–14.
- Haut Conseil de Santé Publique. Tuberculose et test de détéction de l'interféron gamma. France: Haut Conseil de Santé Publique; 2011. Available at: http://www.hcsp.fr/explore.cgi/hcspr20110701interferongamma.pdf (accessed 1 July 2011).
- Keystone EC, Papp KA, Wobeser W. Challenges in diagnosing latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. J Rheumatol 2011;38:1234–43.